Objectives COVID-19 sparked a pandemic in December 2019 and is currently posing a huge impact globally. Chinese herbal medicine is incorporated into the Chinese national guideline for COVID-19 management, emphasising the individualisation of herbal treatment guided by pattern differentiation, which is...
A National Institutes of Health (NIH) expert panel has developed consensus treatment guidelines for the management of coronavirus (COVID-19). To date no drug has been proven to be safe and effective for treating COVID-19. Moreover, they found no evidence to recommended the use of hydroxychlor...
At the recent IDSA media briefing on 18 March 2021, Dr Adarsh Bhimraj from the COVID-19 treatment guidelines expert panel stressed the importance of maintaining efforts to reduce the spread of this pandemic, such as wearing masks, social distancing and continued surveillance and research.6Dr Rajes...
The guidelines consider two broad categories of therapies currently in use byhealthcare providersfor COVID-19: antivirals, which may target the coronavirus directly, and host modifiers and immune-based therapies, which may influence the immune response to the virus or target the virus. The panel'...
On December 8, the Chinese government released a guideline on home treatment for asymptomatic or mild COVID-19 cases, emphasizing the need to effectively fine-tune epidemic prevention and control measures, and provide services while the infected people are staying at home for treatment. On the sa...
According to the proposed guidelines, general considerations during the COVID-19 pandemic stipulate that providers should avoid, if possible, the use of immunosuppressive steroids, minimize patients’ hospital exposure, and employ G-CSF support for patients that are receiving systemic cytotoxic chemotherapy...
Tocilizumab, with the common brand name Actemra, has been included in China's latest version of diagnosis and treatment guidelines on COVID-19. Zhou Qi, deputy secretary-general and an academician of the Chinese Academy of Sciences, said at a press conference Friday that the drug Tocilizumab ha...
Uptake of national guidelines for the treatment of children hospitalized with COVID-19 fell well below what would typically be expected, report researchers at the Medical University of South Carolina (MUSC) and elsewhere in Pediatrics.
China further updated its COVID-19 diagnosis and treatment protocol on Friday. The new guideline, jointly released by the National Health Commission and the National Administration of Traditional Chinese Medicine, is the 10th version since January 2020,
SARS-CoV-2 (COVID-19) has been changing the world since December 2019. A comprehensive search into many COVID-19 treatment guidelines was conducted and reported in this article. This is a review paper to probe differences in COVID-19 managing strategies and explore the most common treatment ...